Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients

Belén Atienza-Mateo, Ana Serrano-Combarro, Jesús Loarce Martos, Nuria Vegas-Revenga, María Martín López, Santos Castañeda, Rafael B. Melero-González, Natalia Mena Vázquez, Carmen Carrasco-Cubero, Carolina Díez Morrondo, David Castro Corredor, Tomás Ramón Vázquez Rodríguez, Andrea García Valle, Gema Bonilla, Marina Rodríguez López, Ignacio Braña Abascal, Sara María Rojas Herrera, Juan C Sarmiento-Monroy, Pablo Andújar Brazal, Diego Ferrer, Iván Ferraz-Amaro, Ricardo Blanco, Delia Fernández Lozano, Cristina Arciniega Larios, Juan Ramón de Dios, Libe Ibarrola, Carmen Gonzalez Montagut, Sergi Ordoñez, Anahy María Brandy-García, Fernando Lozano Morillo, María López Lasanta, Cristina Campos, Marta Garijo Bufort, Ivette Casafont Solé, Mónica Calderón Goercke, Carlota Iñiguez Ubiaga, Francisco Ortiz-Sanjuán, Emilio Giner Serret, Ángela Pecondon Español, Bryan Josué Flores Robles, Mireia Moreno, Virginia Ruiz-Esquide, Evelin Cecilia Cervantes Pérez, Christian Omar Anchorena Diaz

Open source

DOI
10.1016/j.semarthrit.2025.152710
Published
2025-06
Container
Seminars in Arthritis and Rheumatism
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.semarthrit.2025.152710,
  title = {Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients},
  author = {Belén Atienza-Mateo and Ana Serrano-Combarro and Jesús Loarce Martos and Nuria Vegas-Revenga and María Martín López and Santos Castañeda and Rafael B. Melero-González and Natalia Mena Vázquez and Carmen Carrasco-Cubero and Carolina Díez Morrondo and David Castro Corredor and Tomás Ramón Vázquez Rodríguez and Andrea García Valle and Gema Bonilla and Marina Rodríguez López and Ignacio Braña Abascal and Sara María Rojas Herrera and Juan C Sarmiento-Monroy and Pablo Andújar Brazal and Diego Ferrer and Iván Ferraz-Amaro and Ricardo Blanco and Delia Fernández Lozano and Cristina Arciniega Larios and Juan Ramón de Dios and Libe Ibarrola and Carmen Gonzalez Montagut and Sergi Ordoñez and Anahy María Brandy-García and Fernando Lozano Morillo and María López Lasanta and Cristina Campos and Marta Garijo Bufort and Ivette Casafont Solé and Mónica Calderón Goercke and Carlota Iñiguez Ubiaga and Francisco Ortiz-Sanjuán and Emilio Giner Serret and Ángela Pecondon Español and Bryan Josué Flores Robles and Mireia Moreno and Virginia Ruiz-Esquide and Evelin Cecilia Cervantes Pérez and Christian Omar Anchorena Diaz},
  year = {2025},
  journal = {Seminars in Arthritis and Rheumatism},
  doi = {10.1016/j.semarthrit.2025.152710},
  url = {https://doi.org/10.1016/j.semarthrit.2025.152710}
}

RIS

TY  - JOUR
TI  - Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients
AU  - Belén Atienza-Mateo
AU  - Ana Serrano-Combarro
AU  - Jesús Loarce Martos
AU  - Nuria Vegas-Revenga
AU  - María Martín López
AU  - Santos Castañeda
AU  - Rafael B. Melero-González
AU  - Natalia Mena Vázquez
AU  - Carmen Carrasco-Cubero
AU  - Carolina Díez Morrondo
AU  - David Castro Corredor
AU  - Tomás Ramón Vázquez Rodríguez
AU  - Andrea García Valle
AU  - Gema Bonilla
AU  - Marina Rodríguez López
AU  - Ignacio Braña Abascal
AU  - Sara María Rojas Herrera
AU  - Juan C Sarmiento-Monroy
AU  - Pablo Andújar Brazal
AU  - Diego Ferrer
AU  - Iván Ferraz-Amaro
AU  - Ricardo Blanco
AU  - Delia Fernández Lozano
AU  - Cristina Arciniega Larios
AU  - Juan Ramón de Dios
AU  - Libe Ibarrola
AU  - Carmen Gonzalez Montagut
AU  - Sergi Ordoñez
AU  - Anahy María Brandy-García
AU  - Fernando Lozano Morillo
AU  - María López Lasanta
AU  - Cristina Campos
AU  - Marta Garijo Bufort
AU  - Ivette Casafont Solé
AU  - Mónica Calderón Goercke
AU  - Carlota Iñiguez Ubiaga
AU  - Francisco Ortiz-Sanjuán
AU  - Emilio Giner Serret
AU  - Ángela Pecondon Español
AU  - Bryan Josué Flores Robles
AU  - Mireia Moreno
AU  - Virginia Ruiz-Esquide
AU  - Evelin Cecilia Cervantes Pérez
AU  - Christian Omar Anchorena Diaz
PY  - 2025
JO  - Seminars in Arthritis and Rheumatism
DO  - 10.1016/j.semarthrit.2025.152710
UR  - https://doi.org/10.1016/j.semarthrit.2025.152710
ER  - 

APA

Atienza-Mateo, B., Serrano-Combarro, A., Martos, J. L., Vegas-Revenga, N., López, M. M., Castañeda, S., Melero-González, R. B., Vázquez, N. M., Carrasco-Cubero, C., Morrondo, C. D., Corredor, D. C., Rodríguez, T. R. V., Valle, A. G., Bonilla, G., López, M. R., Abascal, I. B., Herrera, S. M. R., Sarmiento-Monroy, J. C., Brazal, P. A., Ferrer, D., Ferraz-Amaro, I., Blanco, R., Lozano, D. F., Larios, C. A., Dios, J. R. D., Ibarrola, L., Montagut, C. G., Ordoñez, S., Brandy-García, A. M., Morillo, F. L., Lasanta, M. L., Campos, C., Bufort, M. G., Solé, I. C., Goercke, M. C., Ubiaga, C. I., Ortiz-Sanjuán, F., Serret, E. G., Español, Á. P., Robles, B. J. F., Moreno, M., Ruiz-Esquide, V., Pérez, E. C. C., & Diaz, C. O. A. (2025). Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients. Seminars in Arthritis and Rheumatism. https://doi.org/10.1016/j.semarthrit.2025.152710

Source records